Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba A, Rodriguez-Fernandez S, Perna-Barrull D, Ampudia RM, Gomez-Muñoz L, Pujol-Autonell I, Aguilera E, Coma M, Cano-Sarabia M, Vázquez F, Verdaguer J, Vives-Pi M.
Front Endocrinol (Lausanne). 2020 May 13;11:258. doi: 10.3389/fendo.2020.00258. eCollection 2020.
PMID:32477262
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
Wessels AM, Scheltens P, Barkhof F, Heine RJ.
Eur J Pharmacol. 2008 May 6;585(1):88-96. doi: 10.1016/j.ejphar.2007.11.080. Epub 2008 Mar 4.
PMID:18396273
A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes.
Bramlage P, Tittel SR, Müther S, Reinhart-Steininger B, Haberland H, Khodaverdi S, Zimny S, Ohlenschläger U, Lanzinger S, Haak T.
Acta Diabetol. 2022 Nov;59(11):1453-1460. doi: 10.1007/s00592-022-01939-3. Epub 2022 Aug 7.
PMID:35933650
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.
Roussel R, Riveline JP, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B.
The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes.
Levy BL, McCann TW Jr, Finan DA.
Eur Endocrinol. 2016 Mar;12(1):18-23. doi: 10.17925/EE.2016.12.01.18. Epub 2016 Mar 15.
PMID:29632582
Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
Charleer S, De Block C, Bolsens N, Van Huffel L, Nobels F, Mathieu C, Gillard P.